Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to Breakthrough Cancer Pain (BTcP) European Guidelines: an Observational Prospective Study.

NCT04468490 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.

NCT NCT04468490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04468490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to Breakthrough Cancer Pain (BTcP) European Guidelines: an Observational Prospective Study.
Lead sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase
Observational
Overall status
Terminated
Start date
August 11, 2020
Completion date
September 30, 2021
Enrollment
131 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breakthrough cancer pain